Announced
Completed
Financials
Tags
Friendly
Acquisition
Single Bidder
Private
United States
drug delivery
Private Equity
Majority
Pharmaceuticals
Completed
Synopsis
Altaris Capital Partners, an investment firm, completed the acquisition of a drug delivery business of 3M, an American multinational conglomerate, for c. $650m. Following the acquisition, Kindeva Drug Delivery, formerly 3M Drug Delivery Systems, launched as an independent company. "We are excited to be partnering with 3M and the Kindeva team in this transaction. We believe Kindeva is well-positioned to build on its successful track record as a leading provider of drug delivery technologies," George Aitken-Davies, Altaris Managing Director.
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.